Meeting
2024 ASCO Genitourinary Cancers Symposium
Rapid quantification of prostate specific antigen (PSA) from fingerstick (FS) blood.
Authors
Joseph Earl Thomas
Weill Cornell Medical Center, NewYork-Presbyterian Hospital, New York, NY
Joseph Earl Thomas , Balaji Srinivasan , Nicole Jacobs , Alfred Winkler , Zhen Zhao , Erica Phillips , Kevin Kensler , Scott T. Tagawa , Jones T. Nauseef , Ana M. Molina , Cora N. Sternberg , Michael Philip Sun , Douglas Scherr , Christopher Barbieri , Jim Hu , Timothy D McClure , Jon Reckler , David Erickson , Saurabh Mehta , David M. Nanus
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Diagnostics and Imaging
Clinical Trial Registration Number
N/A
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 279)
DOI
10.1200/JCO.2024.42.4_suppl.279
Abstract #
279
Poster Bd #
L14
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The performance of prostate specific antigen (PSA) testing in the population based NPCC cohort.
First Author: Jan Oldenburg
Poster
2023 ASCO Genitourinary Cancers Symposium
Disparities in prostate cancer diagnoses in persons experiencing homelessness.
First Author: Zachary S Mayo
Poster
2022 ASCO Annual Meeting
Methylated DNA markers in urine aid in the selective identification of patients with prostate cancer as well as clinically significant pathology.
First Author: Paras Shah
Poster
2022 ASCO Genitourinary Cancers Symposium
Impact of U.S. Preventative Services Task Force grade D recommendation against prostate-specific antigen screening on prostate cancer mortality.
First Author: Laura Burgess